Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial

Published:2021-07 Issue:33 Volume:39 Page:4651-4658
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

At Thobari Jarir,Damayanti Wahyu,Haposan Jonathan Hasian^ORCID,Nirwati Hera,Iskandar Kristy,Samad ,Fahmi Julianita,Sari Rini Mulia,Bachtiar Novilia Sjafri,Watts Emma,Bines Julie E.,Soenarto Yati

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference36 articles.

1. World Health Organization (WHO). Meeting of the immunization Strategic Advisory Group of Experts, April 2009—conclusions and recommendations. Wkly Epidemiol Rec Relev Épidémiologique Hebd 2009;84:220–36.

2. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea;Burnett;J Infect Dis,2017

3. World Health Organization (WHO). Estimated rotavirus deaths for children under 5 years of age: 2013, 215 000 2016. https://www.who.int/immunization/monitoring_surveillance/burden/estimates/rotavirus/en/ (accessed December 31, 2020).

4. International Vaccine Access Center (IVAC) Johns Hopkins Bloomberg School of Public Health. VIEW-hub n.d.

5. World Health Organization (WHO). Immunization Coverage 2020. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage (accessed December 31, 2020).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and safety of a new hexavalent rotavirus vaccine in Chinese infants: A randomized, double-blind, placebo-controlled phase 2 clinical trial;Human Vaccines & Immunotherapeutics;2023-08

2. Circulation of Vaccine-derived Rotavirus G1P[8] in a Vulnerable Child Cohort in Rio de Janeiro;Pediatric Infectious Disease Journal;2022-11-29

3. Current GMP standards for the production of vaccines and antibodies: An overview;Frontiers in Public Health;2022-11-03

4. Rotavirus vaccines: progress and new developments;Expert Opinion on Biological Therapy;2021-09-10